Recombinant GFRA3 (Nadecnemab Biosimilar) antibody
The Human Monoclonal anti-GFRA3 (Nadecnemab Biosimilar) antibody is suitable to detect GFRA3 (Nadecnemab Biosimilar) in samples from Human. It has been validated for ELISA, FACS, BLI, Func and SPR.
Catalog No. ABIN7675891
$346.15
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 10 to 12 Business Days
Quick Overview for Recombinant GFRA3 (Nadecnemab Biosimilar) antibody (ABIN7675891)
Target
GFRA3 (Nadecnemab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Human
Clonality
Monoclonal
Conjugate
This GFRA3 (Nadecnemab Biosimilar) antibody is un-conjugated
Application
ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
Purpose
- Anti-GFRA3 Reference Antibody (nadecnemab)
-
Characteristics
- Anti-GFRA3 Reference Antibody (nadecnemab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
Purity
- >95 %
-
Isotype
- IgG4
-
-
anti-GFRA3 (Nadecnemab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Human Monoclonal unconjugated Recombinant Antibody
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- 1 mg/mL
-
Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- +4°C,-80°C
-
-
- GFRA3 (Nadecnemab Biosimilar)
-
Target Type
- Biosimilar
-
Molecular Weight
- 145.5 kDa
-
UniProt
- O60609
Target
-
You are here:
